Literature DB >> 21732191

The function of dog models in developing gene therapy strategies for human health.

Keri L Nowend1, Alison N Starr-Moss, Keith E Murphy.   

Abstract

The domestic dog is of great benefit to humankind, not only through companionship and working activities cultivated through domestication and selective breeding, but also as a model for biomedical research. Many single-gene traits have been well-characterized at the genomic level, and recent advances in whole-genome association studies will allow for better understanding of complex, multigenic hereditary diseases. Additionally, the dog serves as an invaluable large animal model for assessment of novel therapeutic agents. Thus, the dog has filled a crucial step in the translation of basic research to new treatment regimens for various human diseases. Four well-characterized diseases in canine models are discussed as they relate to other animal model availability, novel therapeutic approach, and extrapolation to human gene therapy trials.

Entities:  

Mesh:

Year:  2011        PMID: 21732191     DOI: 10.1007/s00335-011-9348-0

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  126 in total

1.  Gene therapy: the 'pro-sense' approach to Duchenne muscular dystrophy.

Authors:  Judith C T van Deutekom
Journal:  Eur J Hum Genet       Date:  2005-05       Impact factor: 4.246

Review 2.  Gene therapy for inhereted metabolic disorders in companion animals.

Authors:  Dwight D Koeberl; Carlos Pinto; Talmage Brown; Y T Chen
Journal:  ILAR J       Date:  2009

Review 3.  Structure and function of the leukocyte adhesion molecules CD11/CD18.

Authors:  M A Arnaout
Journal:  Blood       Date:  1990-03-01       Impact factor: 22.113

Review 4.  Gene therapy for leukocyte adhesion deficiency.

Authors:  T R Bauer; D D Hickstein
Journal:  Curr Opin Mol Ther       Date:  2000-08

5.  Canine model and genomic structural organization of glycogen storage disease type Ia (GSD Ia).

Authors:  P S Kishnani; E Faulkner; S VanCamp; M Jackson; T Brown; A Boney; D Koeberl; Y T Chen
Journal:  Vet Pathol       Date:  2001-01       Impact factor: 2.221

6.  Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy.

Authors:  R M Grady; H Teng; M C Nichol; J C Cunningham; R S Wilkinson; J R Sanes
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

7.  Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles.

Authors:  Qi Long Lu; Adam Rabinowitz; Yun Chao Chen; Toshifumi Yokota; HaiFang Yin; Julia Alter; Atif Jadoon; George Bou-Gharios; Terence Partridge
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-17       Impact factor: 11.205

8.  Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice.

Authors:  Natee Jearawiriyapaisarn; Hong M Moulton; Brian Buckley; Jennifer Roberts; Peter Sazani; Suthat Fucharoen; Patrick L Iversen; Ryszard Kole
Journal:  Mol Ther       Date:  2008-06-10       Impact factor: 11.454

9.  Point mutations impairing cell surface expression of the common beta subunit (CD18) in a patient with leukocyte adhesion molecule (Leu-CAM) deficiency.

Authors:  M A Arnaout; N Dana; S K Gupta; D G Tenen; D M Fathallah
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

Review 10.  Understanding hereditary diseases using the dog and human as companion model systems.

Authors:  Kate L Tsai; Leigh Anne Clark; Keith E Murphy
Journal:  Mamm Genome       Date:  2007-07-26       Impact factor: 2.957

View more
  7 in total

1.  Isolation, genetic manipulation, and transplantation of canine spermatogonial stem cells: progress toward transgenesis through the male germ-line.

Authors:  Michael A Harkey; Atsushi Asano; Mary Ellen Zoulas; Beverly Torok-Storb; Jennifer Nagashima; Alexander Travis
Journal:  Reproduction       Date:  2013-06-14       Impact factor: 3.906

Review 2.  Gene therapy in monogenic congenital myopathies.

Authors:  Xuan Guan; Melissa A Goddard; David L Mack; Martin K Childers
Journal:  Methods       Date:  2015-10-14       Impact factor: 3.608

3.  Comparative Genomics of X-linked Muscular Dystrophies: The Golden Retriever Model.

Authors:  Candice Brinkmeyer-Langford; Joe N Kornegay
Journal:  Curr Genomics       Date:  2013-08       Impact factor: 2.236

4.  Genome-wide association study to identify potential genetic modifiers in a canine model for Duchenne muscular dystrophy.

Authors:  Candice Brinkmeyer-Langford; Cynthia Balog-Alvarez; James J Cai; Brian W Davis; Joe N Kornegay
Journal:  BMC Genomics       Date:  2016-08-22       Impact factor: 3.969

Review 5.  Resiniferatoxin: The Evolution of the "Molecular Scalpel" for Chronic Pain Relief.

Authors:  Dorothy Cimino Brown
Journal:  Pharmaceuticals (Basel)       Date:  2016-08-11

Review 6.  Comparative Aspects of Canine Melanoma.

Authors:  Adriana Tomoko Nishiya; Cristina Oliveira Massoco; Claudia Ronca Felizzola; Eduardo Perlmann; Karen Batschinski; Marcello Vannucci Tedardi; Jéssica Soares Garcia; Priscila Pedra Mendonça; Tarso Felipe Teixeira; Maria Lucia Zaidan Dagli
Journal:  Vet Sci       Date:  2016-02-19

Review 7.  Generation of genetically-engineered animals using engineered endonucleases.

Authors:  Jong Geol Lee; Young Hoon Sung; In-Jeoung Baek
Journal:  Arch Pharm Res       Date:  2018-05-17       Impact factor: 4.946

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.